| 1 |
30678291 | Pioglitazone-Primed Mesenchymal Stem Cells Stimulate Cell Proliferation, Collagen Synthesis and Matrix Gene Expression in Tenocytes. | 2019 Jan 22 |
2 |
| 2 |
27347105 | Pioglitazone does not increase the risk of type II diabetes in patients with bladder cancer: A retrospective study. | 2016 Jul |
1 |
| 3 |
24913817 | Loss of miR125a expression in a model of K-ras-dependent pulmonary premalignancy. | 2014 Aug |
1 |
| 4 |
18758684 | Effect of pioglitazone and rosiglitazone on mediators of endothelial dysfunction, markers of angiogenesis and inflammatory cytokines in type-2 diabetes. | 2009 Mar |
1 |
| 5 |
19520186 | Effects of a PPAR-gamma agonist, on growth factor and insulin stimulated endothelial cells. | 2009 Aug-Sep |
2 |
| 6 |
18810647 | PPAR gamma ligands, rosiglitazone and pioglitazone, inhibit bFGF- and VEGF-mediated angiogenesis. | 2008 |
4 |
| 7 |
17786343 | Peroxisome proliferator-activated receptor alpha and gamma ligands inhibit the growth of human ovarian cancer. | 2007 Oct |
1 |
| 8 |
16505497 | Effects of pioglitazone versus glipizide on body fat distribution, body water content, and hemodynamics in type 2 diabetes. | 2006 Mar |
1 |
| 9 |
16508777 | The insulin sensitiser pioglitazone does not influence skin microcirculatory function in patients with type 2 diabetes treated with insulin. | 2006 May |
1 |
| 10 |
10814503 | Peroxisome proliferator-activated receptor-gamma agonists increase vascular endothelial growth factor expression in human vascular smooth muscle cells. | 2000 May 19 |
1 |